Clinical Trial Update: CD5CAR-NK Cells for Refractory Invasive Mold Disease [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating CD5CAR-NK cells for refractory invasive mold disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Mold Disease

Drugs mentioned

• CD5CAR-NK cells

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Fungal Infection | Phase 1 | Status: NOT_YET_RECRUITING